Clinical Trial Update: Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating concurrent Endostar with paclitaxel/carboplatin and radiotherapy for locally advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Endostar (recombinant human endostatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN